Return On Assets of Adaptimmune Therapeutics PLC from 31 Dec 2016 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Adaptimmune Therapeutics PLC quarterly and annual Return On Assets in % history and change rate from 31 Dec 2016 to 30 Jun 2025.
  • Adaptimmune Therapeutics PLC Return On Assets for the quarter ending 30 Jun 2025 was -80%, a 218% decline year-over-year.
  • Adaptimmune Therapeutics PLC annual Return On Assets for 2024 was -25%, a 34% increase from 2023.
  • Adaptimmune Therapeutics PLC annual Return On Assets for 2023 was -38%, a 16% increase from 2022.
  • Adaptimmune Therapeutics PLC annual Return On Assets for 2022 was -45%, a 16% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Adaptimmune Therapeutics PLC Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2025 -80% -55% -218% 01 Apr 2025 30 Jun 2025
Q1 2025 -27% +29% +52% 01 Jan 2025 31 Mar 2025
Q4 2024 -25% +13% +34% 01 Oct 2024 31 Dec 2024
Q3 2024 -15% +15% +50% 01 Jul 2024 30 Sep 2024
Q2 2024 -25% +3% +11% 01 Apr 2024 30 Jun 2024
Q1 2024 -55% -21% -62% 01 Jan 2024 31 Mar 2024
Q4 2023 -38% +7% +16% 01 Oct 2023 31 Dec 2023
Q3 2023 -30% +13% +30% 01 Jul 2023 30 Sep 2023
Q2 2023 -28% +15% +35% 01 Apr 2023 30 Jun 2023
Q1 2023 -34% +8% +18% 01 Jan 2023 31 Mar 2023
Q4 2022 -45% -6% -16% 01 Oct 2022 31 Dec 2022
Q3 2022 -44% -5% -12% 01 Jul 2022 30 Sep 2022
Q2 2022 -43% -9% -26% 01 Apr 2022 30 Jun 2022
Q1 2022 -42% -12% -39% 01 Jan 2022 31 Mar 2022
Q4 2021 -39% -9% -29% 01 Oct 2021 31 Dec 2021
Q3 2021 -39% -5% -15% 01 Jul 2021 30 Sep 2021
Q2 2021 -34% +8% +19% 01 Apr 2021 30 Jun 2021
Q1 2021 -30% +30% +50% 01 Jan 2021 31 Mar 2021
Q4 2020 -30% +31% +51% 01 Oct 2020 31 Dec 2020
Q3 2020 -34% +24% +42% 01 Jul 2020 30 Sep 2020
Q2 2020 -43% -6% -18% 01 Apr 2020 30 Jun 2020
Q1 2020 -60% -22% -58% 01 Jan 2020 31 Mar 2020
Q4 2019 -61% -24% -67% 01 Oct 2019 31 Dec 2019
Q3 2019 -58% -25% -75% 01 Jul 2019 30 Sep 2019
Q2 2019 -36% -1% -1.8% 01 Apr 2019 30 Jun 2019
Q1 2019 -38% -13% -54% 01 Jan 2019 31 Mar 2019
Q4 2018 -37% -12% -48% 01 Oct 2018 31 Dec 2018
Q3 2018 -33% -12% -54% 01 Jul 2018 30 Sep 2018
Q2 2018 -36% -5% -18% 01 Apr 2018 30 Jun 2018
Q1 2018 -25% +8% +23% 01 Jan 2018 31 Mar 2018
Q4 2017 -25% +5% +17% 01 Oct 2017 31 Dec 2017
Q3 2017 -21% 01 Jul 2017 30 Sep 2017
Q2 2017 -30% 01 Apr 2017 30 Jun 2017
Q1 2017 -32% 01 Jan 2017 31 Mar 2017
Q4 2016 -30% 01 Oct 2016 31 Dec 2016

Adaptimmune Therapeutics PLC Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -25% +13% +34% 01 Jan 2024 31 Dec 2024
2023 -38% +7% +16% 01 Jan 2023 31 Dec 2023
2022 -45% -6% -16% 01 Jan 2022 31 Dec 2022
2021 -39% -9% -29% 01 Jan 2021 31 Dec 2021
2020 -30% +31% +51% 01 Jan 2020 31 Dec 2020
2019 -61% -24% -67% 01 Jan 2019 31 Dec 2019
2018 -37% -12% -48% 01 Jan 2018 31 Dec 2018
2017 -25% +5% +17% 01 Jan 2017 31 Dec 2017
2016 -30% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.